Metformin helps reduce weight in children and adolescents with obesity: Study

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-10-08 04:30 GMT   |   Update On 2021-10-08 10:06 GMT
Advertisement

Metformin appears to be safe and effective for children and adolescents with obesity, suggests a study published in the Obesity Journal.

Metformin, sold under the brand name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. It is not associated with weight gain and is taken by mouth. Few treatments exist for pediatric obesity. Metformin holds potential for pediatric weight loss.

Advertisement

A group of researchers from the U.S.A conducted a study to examine the effect of metformin on weight, BMI, BMI z score, and cardiometabolic outcomes.

The study included 7,068 patients aged 10 to 17 years with BMI at or above the 95th percentile and evidence of insulin resistance. The final cohort of 955 patients with BMI data at 0 to 24 months was categorized into three groups: metformin plus intensive lifestyle changes, intensive counselling alone, and routine counselling. In order to adjust for pubertal BMI changes, a subgroup analysis was conducted for adolescents aged 15 to 17 years.

The results of the study are as follows:

· At 6 and 12 months, metformin treatment produced significant reductions in weight, BMI, and BMI z score, which continued to decrease at 24 months, compared with control groups.

· Adolescents aged 15 to 17 years showed similar improvements. Systolic blood pressure and high-density lipoprotein cholesterol also improved in the metformin group.

Thus, the researchers concluded that Metformin with lifestyle interventions significantly reduced weight, BMI, and BMI z score in paediatric patients with obesity and insulin resistance up to 24 months, compared with intensive and routine counselling alone.

Reference:

Metformin for pediatric obesity and insulin resistance: a retrospective study within an integrated health care system by Josephine Q. Concepcion et. al published in the Obesity Journal.

https://doi.org/10.1002/oby.23207

Tags:    
Article Source : Obesity

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News